EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-763.52%
↓ 69% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-450.65%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -763.52% | -155.7% |
| 2024 | -298.63% | -99.2% |
| 2023 | -149.94% | +35.7% |
| 2022 | -233.36% | -71.9% |
| 2021 | -135.76% | -31.7% |
| 2020 | -103.05% | +56.3% |
| 2019 | -235.76% | +81.1% |
| 2018 | -1249.38% | -407.1% |
| 2017 | -246.40% | +77.4% |
| 2016 | -1090.74% | - |